Ignite Creation Date:
2024-05-05 @ 11:24 AM
Last Modification Date:
2024-10-26 @ 9:07 AM
Study NCT ID:
NCT00030966
Status:
COMPLETED
Last Update Posted:
2009-06-18
First Post:
2002-02-15
Brief Title:
Safety and Efficacy of Natalizumab in Combination With Avonex in the Treatment of Multiple Sclerosis
Sponsor:
Biogen
Organization:
Biogen
Key Dates - Follows AllAPIJSON File Order
Start Date:
2002-01
Start Date Type:
None
Primary Completion Date:
2005-04
Primary Completion Date Type:
ACTUAL
Completion Date:
2005-12
Completion Date Type:
ACTUAL
First Submit Date:
2002-02-15
First Submit QC Date:
February 15 2002
Study First Post Date:
2002-02-18
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2009-06-17
Last Update Post Date:
2009-06-18
Last Update Post Date Type:
ESTIMATED